David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Heartland Express
HTLD
$950M
| $1.61M | ﹤0.01% |
86,634
+31,992
| +59% | +$575K |
|
2002
Matthews International
MATW
$675M
| $1.6M | ﹤0.01% |
31,178
+26,551
| +574% | +$1.3M |
|
2003
CALL
Teva Pharmaceuticals
TEVA
$43.6B
| $1.6M | ﹤0.01% |
30,000
-23,200
| -44% | -$1.36M |
|
|
INVN
2004
DELISTED
Invensense Inc
INVN
| $1.6M | ﹤0.01% |
191,105
+98,096
| +105% | +$779K |
|
|
CBPO
2005
PUT
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.6M | ﹤0.01% |
14,000
+8,600
| +159% | +$1.01M |
|
|
ARR
2006
Armour Residential REIT
ARR
$2.31B
| $1.6M | ﹤0.01% |
14,871
-240
| -2% | -$23.8K |
|
|
SIR
2007
DELISTED
SELECT INCOME REIT
SIR
| $1.6M | ﹤0.01% |
158,033
+72,450
| +85% | +$643K |
|
|
PPBI
2008
DELISTED
Pacific Premier Bancorp
PPBI
| $1.6M | ﹤0.01% |
74,851
+33,018
| +79% | +$674K |
|
|
WCIC
2009
DELISTED
WCI Communities, Inc.
WCIC
| $1.6M | ﹤0.01% |
86,047
-46,587
| -35% | -$877K |
|
2010
Tempest Therapeutics
TPST
$18M
| $1.6M | ﹤0.01% |
58
+20
| +53% | +$423K |
|
2011
PUT
T-Mobile US
TMUS
$195B
| $1.59M | ﹤0.01% |
41,600
-57,600
| -58% | -$2.17M |
|
|
EGIO
2012
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.59M | ﹤0.01% |
21,934
+4,180
| +24% | +$239K |
|
2013
Nelnet
NNI
$4.6B
| $1.59M | ﹤0.01% |
40,280
-1,860
| -4% | -$65K |
|
|
CBB
2014
DELISTED
Cincinnati Bell Inc.
CBB
| $1.58M | ﹤0.01% |
81,708
-23,840
| -23% | -$400K |
|
2015
VirnetX Holding Corp
VHC
$54.4M
| $1.58M | ﹤0.01% |
17,210
+1,741
| +11% | +$161K |
|
|
LADR
2016
Ladder Capital
LADR
$1.26B
| $1.58M | ﹤0.01% |
127,633
+11,867
| +10% | +$131K |
|
2017
White Mountains Insurance
WTM
$5.13B
| $1.58M | ﹤0.01% |
1,963
| – | – |
|
2018
Sonida Senior Living
SNDA
$1.98B
| $1.57M | ﹤0.01% |
5,671
-1,175
| -17% | -$306K |
|
2019
CALL
American Electric Power
AEP
$67B
| $1.57M | ﹤0.01% |
23,700
-5,200
| -18% | -$322K |
|
2020
CALL
Abercrombie & Fitch
ANF
$6.43B
| $1.57M | ﹤0.01% |
49,900
+28,500
| +133% | +$800K |
|
2021
Carriage Services
CSV
$555M
| $1.57M | ﹤0.01% |
72,850
+20,149
| +38% | +$430K |
|
2022
PUT
McKesson
MCK
$105B
| $1.57M | ﹤0.01% |
10,000
-152,200
| -94% | -$24.6M |
|
2023
Woodward
WWD
$20.3B
| $1.57M | ﹤0.01% |
+30,200
| New | +$1.44M |
|
2024
Genuine Parts
GPC
$19.1B
| $1.57M | ﹤0.01% |
15,798
-175,262
| -92% | -$15.5M |
|
2025
V2X
VVX
$2.44B
| $1.57M | ﹤0.01% |
68,950
-10,273
| -13% | -$204K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.